MD2B - Pediatric Oncology: Ewings Sarcoma

Amy Feldman, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 23 de julio del 2006

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Cixutumumab Tolerated for Pediatric Refractory Solid Tumors

Dec 22, 2011

Recommended phase II pediatric dose is 9 mg/kg intravenously once per week

More Intensive Chemo Ups Survival in Ewing Sarcoma

Oct 30, 2012

No increased toxicity with increasing chemo from every three weeks to every two weeks

Racial Disparity Seen in Ewing Sarcoma Patients

Nov 27, 2015

Disease is nine times more common among Caucasians than African Americans